BIOMAT Database Logo BIOMAT Database Logo

Novel Epitopes of the Influenza Virus N1 Neuraminidase Targeted by Human Monoclonal Antibodies. 2022

Ericka Kirkpatrick Roubidoux, and Kaori Sano, and Meagan McMahon, and Juan Manuel Carreño, and Christina Capuano, and Kaijun Jiang, and Viviana Simon, and Harm van Bakel, and Patrick Wilson, and Florian Krammer
Department of Microbiology, Icahn School of Medicine at Mount Sinaigrid.59734.3c, New York, New York, USA.

Influenza virus neuraminidase (NA)-targeting antibodies are an independent correlate of protection against influenza. Antibodies against the NA act by blocking enzymatic activity, preventing virus release and transmission. As we advance the development of improved influenza virus vaccines that incorporate standard amounts of NA antigen, it is important to identify the antigenic targets of human monoclonal antibodies (mAbs). Here, we describe escape mutants generated by serial passage of A/Netherlands/602/2009 (H1N1)pdm09 in the presence of human anti-N1 mAbs. We observed escape mutations on the head domain of the N1 protein around the enzymatic site (S364N, N369T, and R430Q) and also detected escape mutations located on the sides and bottom of the NA (N88D, N270D, and Q313K/R). This work increases our understanding of how human antibody responses target the N1 protein. IMPORTANCE As improved influenza virus vaccines are being developed, the influenza virus neuraminidase (NA) is becoming an important new target for immune responses. By identifying novel epitopes of anti-NA antibodies, we can improve vaccine design. Additionally, characterizing escape mutations in these epitopes aids in identifying NA antigenic drift in circulating viruses.

UI MeSH Term Description Entries
D007251 Influenza, Human An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. Grippe,Human Flu,Human Influenza,Influenza in Humans,Influenza,Flu, Human,Human Influenzas,Influenza in Human,Influenzas,Influenzas, Human
D007252 Influenza Vaccines Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more ALPHAINFLUENZAVIRUS and BETAINFLUENZAVIRUS strains. Flu Vaccine,Influenzavirus Vaccine,Monovalent Influenza Vaccine,Universal Flu Vaccine,Universal Influenza Vaccine,Flu Vaccines,High-Dose Trivalent Influenza Vaccine,Influenza Vaccine,Influenza Virus Vaccine,Influenza Virus Vaccines,Influenzavirus Vaccines,Intranasal Live-Attenuated Influenza Vaccine,LAIV Vaccine,Monovalent Influenza Vaccines,Quadrivalent Influenza Vaccine,Trivalent Influenza Vaccine,Trivalent Live Attenuated Influenza Vaccine,Universal Flu Vaccines,Universal Influenza Vaccines,Flu Vaccine, Universal,High Dose Trivalent Influenza Vaccine,Influenza Vaccine, Monovalent,Influenza Vaccine, Quadrivalent,Influenza Vaccine, Trivalent,Influenza Vaccine, Universal,Intranasal Live Attenuated Influenza Vaccine,Vaccine, Flu,Vaccine, Influenza,Vaccine, Influenza Virus,Vaccine, Influenzavirus,Vaccine, LAIV,Vaccine, Monovalent Influenza,Vaccine, Quadrivalent Influenza,Vaccine, Trivalent Influenza,Virus Vaccine, Influenza
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009439 Neuraminidase An enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages (at a decreasing rate, respectively) of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. (From Enzyme Nomenclature, 1992) Sialidase,Exo-alpha-Sialidase,N-Acylneuraminate Glycohydrolases,Oligosaccharide Sialidase,Exo alpha Sialidase,Glycohydrolases, N-Acylneuraminate,N Acylneuraminate Glycohydrolases,Sialidase, Oligosaccharide
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D053118 Influenza A Virus, H1N1 Subtype A subtype of INFLUENZA A VIRUS with the surface proteins hemagglutinin 1 and neuraminidase 1. The H1N1 subtype was responsible for the Spanish flu pandemic of 1918 and 2009 H1N1 pandemic. H1N1 Influenza Virus,H1N1 Virus,H1N1 subtype,H1N1v Viruses,Influenza A (H1N1)pdm09,Influenza A (H1N1)pdm09 Virus,Influenza A H1N1, Variant Virus,Swine-Origin Influenza A H1N1 Virus,H1N1 Influenza Viruses,H1N1 Viruses,H1N1 subtypes,H1N1v Virus,Influenza Virus, H1N1,Swine Origin Influenza A H1N1 Virus,Virus, H1N1,Virus, H1N1 Influenza,Virus, H1N1v,subtype, H1N1

Related Publications

Ericka Kirkpatrick Roubidoux, and Kaori Sano, and Meagan McMahon, and Juan Manuel Carreño, and Christina Capuano, and Kaijun Jiang, and Viviana Simon, and Harm van Bakel, and Patrick Wilson, and Florian Krammer
H1N1 influenza virus epitopes classified by monoclonal antibodies.
September 2018, Experimental and therapeutic medicine,
Ericka Kirkpatrick Roubidoux, and Kaori Sano, and Meagan McMahon, and Juan Manuel Carreño, and Christina Capuano, and Kaijun Jiang, and Viviana Simon, and Harm van Bakel, and Patrick Wilson, and Florian Krammer
Monoclonal antibodies targeting the influenza virus N6 neuraminidase.
January 2022, Frontiers in immunology,
Ericka Kirkpatrick Roubidoux, and Kaori Sano, and Meagan McMahon, and Juan Manuel Carreño, and Christina Capuano, and Kaijun Jiang, and Viviana Simon, and Harm van Bakel, and Patrick Wilson, and Florian Krammer
Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes.
October 2017, Nature microbiology,
Ericka Kirkpatrick Roubidoux, and Kaori Sano, and Meagan McMahon, and Juan Manuel Carreño, and Christina Capuano, and Kaijun Jiang, and Viviana Simon, and Harm van Bakel, and Patrick Wilson, and Florian Krammer
Comparative Efficacy of Monoclonal Antibodies That Bind to Different Epitopes of the 2009 Pandemic H1N1 Influenza Virus Neuraminidase.
January 2016, Journal of virology,
Ericka Kirkpatrick Roubidoux, and Kaori Sano, and Meagan McMahon, and Juan Manuel Carreño, and Christina Capuano, and Kaijun Jiang, and Viviana Simon, and Harm van Bakel, and Patrick Wilson, and Florian Krammer
Effect of monoclonal anti-neuraminidase antibodies on the kinetic behavior of influenza virus neuraminidase.
June 1982, Molecular immunology,
Ericka Kirkpatrick Roubidoux, and Kaori Sano, and Meagan McMahon, and Juan Manuel Carreño, and Christina Capuano, and Kaijun Jiang, and Viviana Simon, and Harm van Bakel, and Patrick Wilson, and Florian Krammer
Can immunity induced by the human influenza virus N1 neuraminidase provide some protection from avian influenza H5N1 viruses?
February 2007, PLoS medicine,
Ericka Kirkpatrick Roubidoux, and Kaori Sano, and Meagan McMahon, and Juan Manuel Carreño, and Christina Capuano, and Kaijun Jiang, and Viviana Simon, and Harm van Bakel, and Patrick Wilson, and Florian Krammer
Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidase.
March 2024, Immunity,
Ericka Kirkpatrick Roubidoux, and Kaori Sano, and Meagan McMahon, and Juan Manuel Carreño, and Christina Capuano, and Kaijun Jiang, and Viviana Simon, and Harm van Bakel, and Patrick Wilson, and Florian Krammer
Broadly Protective Neuraminidase-Based Influenza Vaccines and Monoclonal Antibodies: Target Epitopes and Mechanisms of Action.
January 2023, Viruses,
Ericka Kirkpatrick Roubidoux, and Kaori Sano, and Meagan McMahon, and Juan Manuel Carreño, and Christina Capuano, and Kaijun Jiang, and Viviana Simon, and Harm van Bakel, and Patrick Wilson, and Florian Krammer
Drugs against avian influenza a virus: design of novel sulfonate inhibitors of neuraminidase N1.
January 2014, Current pharmaceutical design,
Ericka Kirkpatrick Roubidoux, and Kaori Sano, and Meagan McMahon, and Juan Manuel Carreño, and Christina Capuano, and Kaijun Jiang, and Viviana Simon, and Harm van Bakel, and Patrick Wilson, and Florian Krammer
Antigenic and biological characterization of influenza virus neuraminidase (N2) with monoclonal antibodies.
May 1984, Virology,
Copied contents to your clipboard!